Skyrizi Injection

Product Information:

• Type of medication: Skyrizi is a biologic drug (monoclonal antibody) used to treat moderate-to-severe plaque psoriasis, a skin condition that causes red, scaly patches.

• How it works: It targets a protein called IL-23, which is involved in inflammation, helping reduce psoriasis symptoms.

How Skyrizi is Taken:

• Form: Skyrizi is given as a subcutaneous injection (under the skin).

• Schedule: Usually:

  • First dose: Week 0

  • Second dose: Week 4

  • Then: Every 12 weeks (maintenance)

• Administration: Can be injected by a healthcare professional or at home if trained.

• Important: Use exactly as prescribed; do not change the dose or schedule.

Warnings:

1. Infections: Skyrizi can weaken your immune system. Avoid exposure to tuberculosis (TB) and other infections.

2. Allergic reactions: Rare but serious reactions can occur after injection.

3. Vaccines: Avoid live vaccines while on Skyrizi.

4. Pregnancy / breastfeeding: Should be discussed with your doctor.

Side Effects:

• Redness, pain, or swelling at the injection site

• Upper respiratory infections (cold-like symptoms)

• Fatigue

• Headache

• Itching

Serious side effects (contact a doctor immediately):

• Signs of infection (fever, cough, sore throat)

• Severe allergic reaction (rash, swelling, trouble breathing)

Skyrizi is effective for controlling psoriasis but must be used under medical supervision to manage risks and monitor for side effects.